Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02176694 · ClinicalTrials.gov registry record · NA

Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care

A NA study of Persistent Asthma, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT02176694: Completed NA study of Persistent Asthma, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT02176694 is a NA study of Persistent Asthma that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02176694, a NA study of Persistent Asthma, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

A randomized controlled trial of a texting intervention to increase adherence to preventative asthma medication in four Cincinnati Children's Hospital Medical Center primary care clinics.

Primary Outcome

Electronic monitor logs

Conditions Studied

Interventions

  • BEHAVIORAL Text Messaging

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2014-06
Est. Completion 2015-12
Phase NA

What the finished NCT02176694 record still lists

NCT02176694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Persistent Asthma appearing as the primary indexed condition, and to 1 intervention - of which Text Messaging is the first listed.

NCT02176694 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02176694 about?

NCT02176694 is a clinical study titled "Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care". A randomized controlled trial of a texting intervention to increase adherence to preventative asthma medication in four Cincinnati Children's Hospital Medical Center primary care clinics.

What is the current status of trial NCT02176694?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2014-06. Estimated completion is 2015-12.

What conditions does trial NCT02176694 study?

This clinical trial studies the following conditions: Persistent Asthma.

What interventions are being tested in trial NCT02176694?

The interventions under investigation include: Text Messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT02176694?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02176694 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02176694's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02176694, the US trial registry maintained by the National Library of Medicine. NCT02176694 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.